Unimed NTZ
Executive Summary
FDA grants priority review status to the nitazoxanide NDA submitted Dec. 30 for the treatment of diarrhea associated with cryptosporidiosis ("The Pink Sheet" Jan. 19, In Brief)...
FDA grants priority review status to the nitazoxanide NDA submitted Dec. 30 for the treatment of diarrhea associated with cryptosporidiosis ("The Pink Sheet" Jan. 19, In Brief).... |